BioWave’s proprietary technology was developed and born in professional sports in conjunction with the New York Giants football team through a clinical study treating pain from acute and chronic injuries in professional football players. This study and others were the basis for our first FDA clearance.
After getting its first FDA clearance, BioWave built a strong customer base in professional, collegiate, and Olympic sports which continues to this day. Professional & Collegiate Athletic trainers consider BioWave a go-to modality to help their athletes manage pain through their recovery and rehabilitation from sports related injuries. In 2017 BioWave began helping patients of the Veterans Administration, Department of Labor and Active Military manage their acute and chronic pain conditions. To date BioWave has been prescribed by over 140 Federal Healthcare VA Сlinics resulting in a number of white papers and a published study that document successful outcomes for patients who used BioWave. BioWave’s prescription products have been prescribed to over 500 professional athletes and are used by over 105 professional sports teams in the NFL, MLB, NBA, NHL and MLS and by over 140 college sports teams.